Coherent with this notion, NOS3, the enzyme required for constitutive NO formation in ECs has been shown to be downregulated in ECs harvested from HHT patients [31], a pathology due to heterozygous mutations in either endoglin or Alk1 and characterized by multiple vascular malformations. This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.